The learning objectives (LO) set by the course are to acquire the following: LO1) Basic technical knowledge for physical, chemical and biological characterization applied to pharmaceutical nanotechnologies LO2) Advanced technical knowledge for physical, chemical and biological characterization applied to nanomedicines LO3) Knowledge on how to classify Nanomedicines’ Technical Readiness Level (TRL) LO4) Knowledge on Nanomedicines’ translational process LO5) Knowledge on how to classify Nanomedicines based on regulatory landscape. The Key Performance Indicator (KPI) to evaluate the acquisition of knowledge are the following: KPI1) Group based discussion on the rational for selection and use of characterization techniques for nanomedicines KPI2) Technical Readiness Level assessment for nanomedicines and technological advancement (problem based learning (PBL)) KPI3) Identification and development of translational process for nanomedicine: from synthesis to final product (PBL).
Course Prerequisites
It would be beneficial if the students registered for the module would have background knowledge, acquired from prior modules. Ideally, the most common industrial pharmaceutical nanobiotechnologies.
Teaching Methods
The teaching methods use in this module are: 1). Active learning 2). Active participation and interaction (for each student) 3). Active participation and interaction within small working group 4). Problem Based Learning 5). Case studies
Assessment Methods
Knowledge Assessment of each student based on interaction and contribution to the class Knowledge Assessment of each student based on group activities Knowledge Assessment of each student based on PBL
Texts
All lecture materials will be provided ahead of the scheduled lectures to facilitate the initial grasping of concept and theoretical knowledge, enable the preparation for group-based activities and the group interaction during PBL.
Contents
The module focus will be centred on the delivery of basic and advanced knowledge of the preclinical and translational processes behind the development of nanomedicines: from the laboratory to industry. The module learning and training is divided in two parts: 1) development of basic and advanced knowledge. 2) development of decision making process and methodology deployment (PBL) The module content is aligned to the learning objectives: Part 1) Lecture content delivery and debate around the application of basic technical knowledge for physical, chemical and biological characterization applied to pharmaceutical nanotechnologies (5 hrs) Part 2) Lecture content delivery, debate and practical application of advanced technical knowledge for physical, chemical and biological characterization applied to nanomedicines (5 hrs) Part 3) Lecture content delivery, debate and practical application of knowledge on how to classify Nanomedicines’ Technical Readiness Level (TRL) (4 hrs) Part 4) Lecture content delivery, debate and practical application of knowledge on Nanomedicines’ translational process (5 hrs) Part 5) Lecture content delivery, debate and practical application of knowledge on how to classify Nanomedicines based on regulatory landscape. (5 hrs)
